Global Liver Cancer Therapeutics Market, By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Liver Metastasis, Hepatoblastoma, Angiosarcoma), By Therapy (Targeted Therapy, Radiation and Chemotherapy Therapy, Immunotherapy, Others), By Equipment (Computed Radiography, MRI, Sonography, Others), By Age (0-18, 18-35, 35-50, 50+), By Factors (Non-Alcoholic Fatty Liver Disease, Cirrhosis, Excessive Liver Consumption, Others), By Route of Administration (Oral, Intra-Venous, Others ), By Distribution channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2025

August 2020 | 129 pages | ID: G2D340570FB0EN
TechSci Research

Abstracts

Global liver cancer therapeutics market is forecast to grow in the coming years and reach $ 11 billion by 2025. Major factors behind the growth of this market include rising cases of liver cancer, globally, increasing alcohol consumption, aging population, and growing funding by both public and private sector in research and development activities for cancer cure. Liver cancer is a chronic and life-threatening disease which begins in cells of liver. Most of the liver cancer patients do not show the symptoms at early stages but in later stages, the common symptoms include loss of appetite, upper abdominal pain, nausea and vomiting and yellow discoloration of skin. According to World Cancer Research Fund, liver cancer is the sixth most common cancer across the globe. Another major reason for the increase in the liver cancer is the high increase in the incidence of HBV/HCV coinfection and cirrhosis. Therefore, scientists are working on developing more innovative drugs and therapies for liver cancer treatment. However, the market also faces some restrains. Expensive treatments as well as high cost in research and development might hamper further development of liver cancer therapeutics market.

The global liver cancer therapeutics market is segmented based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region. Based on route of administration, the market is segmented into oral, intravenous and others. The oral segment is anticipated to dominate the global liver cancer therapeutics market during the forecast period as it is most preferred route of administration for chemotherapy. Based on distribution channel the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacies are anticipated to dominate the market during the forecast period as the drugs are mostly purchased from the hospitals at the time of treatment. Based on therapy the market is segmented into chemotherapy and radiation therapy, immunotherapy, targeted therapy, and others. The chemotherapy and radiation therapy segment is anticipated to dominate the market through 2025.

The onset of COVID-19 has adversely impacted the market on account of significantly lower patient footfall in private clinics and hospital OPDs. Major players operating in the global liver cancer therapeutics market include Bayer AG, Alnylam Pharmaceuticals Inc., F. Hoffmann-La Roche AG , Bristol-Myers Squibb Company, Eisai Co., Ltd. , Pfizer Inc., Exelixis, Inc., Merck, Celsion Corporation, Johnson & Johnson, Novartis International AG, Sanofi S.A., Eli Lilly and Company, Perkin Elmer, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Amgen Inc., AstraZeneca, Philips Healthcare Pvt. Ltd and others.

Years considered for this report:

• Historical Years: 2015-2018
• Base Year: 2019
• Estimated Year: 2020
• Forecast Period: 2021–2025

Objective of the Study:

• To analyze and forecast the market size of global liver cancer therapeutics market.
• To classify and forecast global liver cancer therapeutics market based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region.
• To identify drivers and challenges for global liver cancer therapeutics market.
• To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global liver cancer therapeutics market.
• To conduct pricing analysis for global liver cancer therapeutics market.
• To identify and analyze the profile of leading players operating in global liver cancer therapeutics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include market players, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the market players, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global liver cancer therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

• Liver cancer therapeutics players and other stakeholders
• Government bodies such as regulating authorities and policy makers
• Organizations, forums and alliances related to liver cancer therapeutics
• Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as market players, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global liver cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Market, By Cancer Type:
• Hepatocellular Carcinoma
• Cholangiocarcinoma
• Hepatoblastoma
• Angiosarcoma
• Liver Metastasis
• Market, By Therapy:
• Targeted Therapy
• Chemotherapy and Radiation Therapy
• Immunotherapy
• Others
• Market, By Equipment:
• Computed Radiography
• Sonography
• MRI
• Others
• Market, By Age:
• 0-18
• 18-35
• 35-50
• 50+
• Market, By Factors:
• Cirrhosis
• Nonalcoholic Fatty Liver Disease
• Excessive Alcohol Consumption
• Others
• Market, By Route of Administration:
• Oral
• Intravenous
• Others
• Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Market, By Region:
• North America
• United States
• Canada
• Mexico
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global liver cancer therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Contents

1. PRODUCT OVERVIEW

2. RESEARCH METHODOLOGY

3. IMPACT OF COVID-19 ON GLOBAL LIVER CANCER THERAPEUTICS MARKET

4. VOICE OF CUSTOMER

5. EXECUTIVE SUMMARY

6. GLOBAL LIVER CANCER THERAPEUTICS MARKET OUTLOOK

6.1. Market Size & Forecast
  6.1.1. By Value
6.2. Market Share & Forecast
  6.2.1. By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma, Liver Metastasis)
  6.2.2. By Therapy (Targeted Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, Others)
  6.2.3. By Equipment (Computed Radiography, Sonography, MRI, Others)
  6.2.4. By Age (0-18, 18-35, 35-50, 50+)
  6.2.5. By Factors (Cirrhosis, Nonalcoholic Fatty Liver Disease, Excessive Alcohol Consumption, Others)
  6.2.6. By Route of Administration (Oral, Intravenous, Others)
  6.2.7. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)
  6.2.8. By Company (2019)
  6.2.9. By Region
6.3. Market Attractiveness Index

7. ASIA-PACIFIC LIVER CANCER THERAPEUTICS MARKET OUTLOOK

7.1. Market Size & Forecast
  7.1.1. By Value
7.2. Market Share & Forecast
  7.2.1. By Cancer Type
  7.2.2. By Therapy
  7.2.3. By Equipment
  7.2.4. By Age
  7.2.5. By Factors
  7.2.6. By Route of Administration
  7.2.7. By Country
7.3. Asia-Pacific: Country Analysis
  7.3.1. China Liver Cancer Therapeutics Market Outlook
    7.3.1.1. Market Size & Forecast
      7.3.1.1.1. By Value
    7.3.1.2. Market Share & Forecast
      7.3.1.2.1. By Cancer Type
      7.3.1.2.2. By Therapy
      7.3.1.2.3. By Equipment
      7.3.1.2.4. By Age
      7.3.1.2.5. By Factors
      7.3.1.2.6. By Route of Administration
  7.3.2. India Liver Cancer Therapeutics Market Outlook
    7.3.2.1. Market Size & Forecast
      7.3.2.1.1. By Value
    7.3.2.2. Market Share & Forecast
      7.3.2.2.1. By Cancer Type
      7.3.2.2.2. By Therapy
      7.3.2.2.3. By Equipment
      7.3.2.2.4. By Age
      7.3.2.2.5. By Factors
      7.3.2.2.6. By Route of Administration
  7.3.3. Japan Liver Cancer Therapeutics Market Outlook
    7.3.3.1. Market Size & Forecast
      7.3.3.1.1. By Value
    7.3.3.2. Market Share & Forecast
      7.3.3.2.1. By Cancer Type
      7.3.3.2.2. By Therapy
      7.3.3.2.3. By Equipment
      7.3.3.2.4. By Age
      7.3.3.2.5. By Factors
      7.3.3.2.6. By Route of Administration
  7.3.4. South Korea Liver Cancer Therapeutics Market Outlook
    7.3.4.1. Market Size & Forecast
      7.3.4.1.1. By Value
    7.3.4.2. Market Share & Forecast
      7.3.4.2.1. By Cancer Type
      7.3.4.2.2. By Therapy
      7.3.4.2.3. By Equipment
      7.3.4.2.4. By Age
      7.3.4.2.5. By Factors
      7.3.4.2.6. By Route of Administration
  7.3.5. Australia Liver Cancer Therapeutics Market Outlook
    7.3.5.1. Market Size & Forecast
      7.3.5.1.1. By Value
    7.3.5.2. Market Share & Forecast
      7.3.5.2.1. By Cancer Type
      7.3.5.2.2. By Therapy
      7.3.5.2.3. By Equipment
      7.3.5.2.4. By Age
      7.3.5.2.5. By Factors
      7.3.5.2.6. By Route of Administration

8. EUROPE LIVER CANCER THERAPEUTICS MARKET OUTLOOK

8.1. Market Size & Forecast
  8.1.1. By Value
8.2. Market Share & Forecast
  8.2.1. By Cancer Type
  8.2.2. By Therapy
  8.2.3. By Equipment
  8.2.4. By Age
  8.2.5. By Factors
  8.2.6. By Route of Administration
  8.2.7. By Country
8.3. Europe: Country Analysis
  8.3.1. France Liver Cancer Therapeutics Market Outlook
    8.3.1.1. Market Size & Forecast
      8.3.1.1.1. By Value
    8.3.1.2. Market Share & Forecast
      8.3.1.2.1. By Cancer Type
      8.3.1.2.2. By Therapy
      8.3.1.2.3. By Equipment
      8.3.1.2.4. By Age
      8.3.1.2.5. By Factors
      8.3.1.2.6. By Route of Administration
  8.3.2. Germany Liver Cancer Therapeutics Market Outlook
    8.3.2.1. Market Size & Forecast
      8.3.2.1.1. By Value
    8.3.2.2. Market Share & Forecast
      8.3.2.2.1. By Cancer Type
      8.3.2.2.2. By Therapy
      8.3.2.2.3. By Equipment
      8.3.2.2.4. By Age
      8.3.2.2.5. By Factors
      8.3.2.2.6. By Route of Administration
  8.3.3. United Kingdom Liver Cancer Therapeutics Market Outlook
    8.3.3.1. Market Size & Forecast
      8.3.3.1.1. By Value
    8.3.3.2. Market Share & Forecast
      8.3.3.2.1. By Cancer Type
      8.3.3.2.2. By Therapy
      8.3.3.2.3. By Equipment
      8.3.3.2.4. By Age
      8.3.3.2.5. By Factors
      8.3.3.2.6. By Route of Administration
  8.3.4. Italy Liver Cancer Therapeutics Market Outlook
    8.3.4.1. Market Size & Forecast
      8.3.4.1.1. By Value
    8.3.4.2. Market Share & Forecast
      8.3.4.2.1. By Cancer Type
      8.3.4.2.2. By Therapy
      8.3.4.2.3. By Equipment
      8.3.4.2.4. By Age
      8.3.4.2.5. By Factors
      8.3.4.2.6. By Route of Administration
  8.3.5. Spain Liver Cancer Therapeutics Market Outlook
    8.3.5.1. Market Size & Forecast
      8.3.5.1.1. By Value
    8.3.5.2. Market Share & Forecast
      8.3.5.2.1. By Cancer Type
      8.3.5.2.2. By Therapy
      8.3.5.2.3. By Equipment
      8.3.5.2.4. By Age
      8.3.5.2.5. By Factors
      8.3.5.2.6. By Route of Administration

9. NORTH AMERICA LIVER CANCER THERAPEUTICS MARKET OUTLOOK

9.1. Market Size & Forecast
  9.1.1. By Value
9.2. Market Share & Forecast
  9.2.1. By Cancer Type
  9.2.2. By Therapy
  9.2.3. By Equipment
  9.2.4. By Age
  9.2.5. By Factors
  9.2.6. By Route of Administration
  9.2.7. By Country
9.3. North America: Country Analysis
  9.3.1. United States Liver Cancer Therapeutics Market Outlook
    9.3.1.1. Market Size & Forecast
      9.3.1.1.1. By Value
    9.3.1.2. Market Share & Forecast
      9.3.1.2.1. By Cancer Type
      9.3.1.2.2. By Therapy
      9.3.1.2.3. By Equipment
      9.3.1.2.4. By Age
      9.3.1.2.5. By Factors
      9.3.1.2.6. By Route of Administration
  9.3.2. Mexico Liver Cancer Therapeutics Market Outlook
    9.3.2.1. Market Size & Forecast
      9.3.2.1.1. By Value
    9.3.2.2. Market Share & Forecast
      9.3.2.2.1. By Cancer Type
      9.3.2.2.2. By Therapy
      9.3.2.2.3. By Equipment
      9.3.2.2.4. By Age
      9.3.2.2.5. By Factors
      9.3.2.2.6. By Route of Administration
  9.3.3. Canada Liver Cancer Therapeutics Market Outlook
    9.3.3.1. Market Size & Forecast
      9.3.3.1.1. By Value
    9.3.3.2. Market Share & Forecast
      9.3.3.2.1. By Cancer Type
      9.3.3.2.2. By Therapy
      9.3.3.2.3. By Equipment
      9.3.3.2.4. By Age
      9.3.3.2.5. By Factors
      9.3.3.2.6. By Route of Administration

10. SOUTH AMERICA LIVER CANCER THERAPEUTICS MARKET OUTLOOK

10.1. Market Size & Forecast
  10.1.1. By Value
10.2. Market Share & Forecast
  10.2.1. By Cancer Type
  10.2.2. By Therapy
  10.2.3. By Equipment
  10.2.4. By Age
  10.2.5. By Factors
  10.2.6. By Route of Administration
  10.2.7. By Country
10.3. South America: Country Analysis
  10.3.1. Brazil Liver Cancer Therapeutics Market Outlook
    10.3.1.1. Market Size & Forecast
      10.3.1.1.1. By Value
    10.3.1.2. Market Share & Forecast
      10.3.1.2.1. By Cancer Type
      10.3.1.2.2. By Therapy
      10.3.1.2.3. By Equipment
      10.3.1.2.4. By Age
      10.3.1.2.5. By Factors
      10.3.1.2.6. By Route of Administration
  10.3.2. Argentina Liver Cancer Therapeutics Market Outlook
    10.3.2.1. Market Size & Forecast
      10.3.2.1.1. By Value
    10.3.2.2. Market Share & Forecast
      10.3.2.2.1. By Cancer Type
      10.3.2.2.2. By Therapy
      10.3.2.2.3. By Equipment
      10.3.2.2.4. By Age
      10.3.2.2.5. By Factors
      10.3.2.2.6. By Route of Administration
  10.3.3. Colombia Liver Cancer Therapeutics Market Outlook
    10.3.3.1. Market Size & Forecast
      10.3.3.1.1. By Value
    10.3.3.2. Market Share & Forecast
      10.3.3.2.1. By Cancer Type
      10.3.3.2.2. By Therapy
      10.3.3.2.3. By Equipment
      10.3.3.2.4. By Age
      10.3.3.2.5. By Factors
      10.3.3.2.6. By Route of Administration

11. MIDDLE EAST AND AFRICA LIVER CANCER THERAPEUTICS MARKET OUTLOOK

11.1. Market Size & Forecast
  11.1.1. By Value
11.2. Market Share & Forecast
  11.2.1. By Cancer Type
  11.2.2. By Therapy
  11.2.3. By Equipment
  11.2.4. By Age
  11.2.5. By Factors
  11.2.6. By Route of Administration
  11.2.7. By Country
11.3. MEA: Country Analysis
  11.3.1. South Africa Liver Cancer Therapeutics Market Outlook
    11.3.1.1. Market Size & Forecast
      11.3.1.1.1. By Value
    11.3.1.2. Market Share & Forecast
      11.3.1.2.1. By Cancer Type
      11.3.1.2.2. By Therapy
      11.3.1.2.3. By Equipment
      11.3.1.2.4. By Age
      11.3.1.2.5. By Factors
      11.3.1.2.6. By Route of Administration
  11.3.2. Saudi Arabia Liver Cancer Therapeutics Market Outlook
    11.3.2.1. Market Size & Forecast
      11.3.2.1.1. By Value
    11.3.2.2. Market Share & Forecast
      11.3.2.2.1. By Cancer Type
      11.3.2.2.2. By Therapy
      11.3.2.2.3. By Equipment
      11.3.2.2.4. By Age
      11.3.2.2.5. By Factors
      11.3.2.2.6. By Route of Administration
  11.3.3. UAE Liver Cancer Therapeutics Market Outlook
    11.3.3.1. Market Size & Forecast
      11.3.3.1.1. By Value
    11.3.3.2. Market Share & Forecast
      11.3.3.2.1. By Cancer Type
      11.3.3.2.2. By Therapy
      11.3.3.2.3. By Equipment
      11.3.3.2.4. By Age
      11.3.3.2.5. By Factors
      11.3.3.2.6. By Route of Administration

12. MARKET DYNAMICS

12.1. Drivers
12.2. Challenges

13. MARKET TRENDS & DEVELOPMENTS

14. COMPETITIVE LANDSCAPE

14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
  14.2.1. AbbVie Inc.
  14.2.2. Alnylam Pharmaceuticals Inc.
  14.2.3. Amgen Inc.
  14.2.4. AstraZeneca
  14.2.5. Bayer AG
  14.2.6. Bristol-Myers Squibb Company
  14.2.7. Celsion Corporation
  14.2.8. Eisai Co., Ltd.
  14.2.9. Eli Lilly and Company
  14.2.10. Exelixis, Inc.
  14.2.11. F. Hoffmann-La Roche AG
  14.2.12. Johnson & Johnson
  14.2.13. Merck
  14.2.14. Novartis International AG
  14.2.15. Perkin Elmer
  14.2.16. Pfizer Inc.
  14.2.17. Philips Healthcare Pvt. Ltd
  14.2.18. Sanofi S.A.
  14.2.19. Sun Pharmaceutical Industries Ltd.

15. STRATEGIC RECOMMENDATIONS

16. ABOUT US & DISCLAIMER

List Of Figures

LIST OF FIGURES

Figure 1: Global Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)
Figure 2: Global Per Capita Health Expenditure, In USD, 2015-2019
Figure 3: Global Liver Cancer Therapeutic Market Share, By Cancer Type, By Value, 2015-2025F
Figure 4: Global Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F
Figure 5: Global Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F
Figure 6: Global Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F
Figure 7: Global Liver Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F
Figure 8: Global Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F
Figure 9: Global Liver Cancer Therapeutic Market Share, By Distribution Channel, By Value, 2019 & 2025F
Figure 10: Global Liver Cancer Therapeutic Market Share, By Region, By Value, 2019 & 2025F
Figure 11: Global Liver Cancer Therapeutic Market Share, By Company, By Value, 2019
Figure 12: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Cancer Type, 2020E-2025F
Figure 13: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Therapy, 2020E-2025F
Figure 14: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Region, 2020E-2025F
Figure 15: Asia-Pacific Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)
Figure 16: Asia Pacific Liver Cancer Therapeutics Market Share, By Cancer Type, By Value, 2015-2025F
Figure 17: Asia Pacific Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F
Figure 18: Asia Pacific Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F
Figure 19: Asia Pacific Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F
Figure 20: Asia Pacific Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F
Figure 21: Asia Pacific Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F
Figure 22: Asia Pacific Liver Cancer Therapeutic Market Share, By Country, By Value, 2019 & 2025F
Figure 23: Japan Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 24: Japan Total Health Expenditure as a share of GDP, 2015- 2019
Figure 25: Japan Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 26: Japan Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 27: Japan Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 28: Japan Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 29: Japan Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 30: Japan Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 31: China Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 32: China Number of Health Checks, By Volume, 2012, 2015, 2017, 2019, 2020E, 2025F (Billion)
Figure 33: China Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 34: China Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 35: China Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 36: China Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 37: China Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 38: China Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 39: India Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 40: India No of Hospitalized Cases For The Treatment of Patients, 2008, 2013 & 2019
Figure 41: India Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 42: India Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 43: India Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 44: India Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 45: India Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 46: India Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 47: South Korea Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
Figure 48: South Korea Per Capita Expenditure On Health, By Value, ‘000 USD, 2015-2020E
Figure 49: South Korea Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 50: South Korea Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 51: South Korea Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 52: South Korea Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 53: South Korea Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 54: South Korea Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 55: Australia Liver Cancer Therapeutics Market Size, By Value 2015-2025F (USD Billion)
Figure 56: Australia Enterprise Healthcare Spending, By Value (USD Billion) 2017-2021E
Figure 57: Australia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 58: Australia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 59: Australia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 60: Australia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 61: Australia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 62: Australia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 63: Europe Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
Figure 64: Europe Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 65: Europe Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 66: Europe Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 67: Europe Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 68: Europe Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 69: Europe Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 70: Europe Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
Figure 71: Germany Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
Figure 72: Germany New Cases of Cancer, By Type, 2019
Figure 73: Germany Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 74: Germany Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 75: Germany Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 76: Germany Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 77: Germany Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 78: Germany Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 79: France Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 80: France Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 81: France Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 82: France Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 83: France Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 84: France Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 85: France Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 86: United Kingdom Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 87: United Kingdom Healthcare Spending, By Value (USD Per Capita), 2015-2018
Figure 88: United Kingdom Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 89: United Kingdom Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 90: United Kingdom Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 91: United Kingdom Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 92: United Kingdom Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 93: United Kingdom Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 94: Italy Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 95: Italy Per Capita Expenditure On Health, By Value, ‘000 USD, 2015-2020E
Figure 96: Italy Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 97: Italy Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 98: Italy Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 99: Italy Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 100: Italy Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 101: Italy Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 102: Spain Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 103: Spain Hospital Beds, By Volume, 2014–2020E
Figure 104: Spain Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 105: Spain Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 106: Spain Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 107: Spain Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 108: Spain Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 109: Spain Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 110: North America Liver Cancer Therapeutics Market Size, By Value
Figure 111: North America Health Spending Share, By Value, 2020E
Figure 112: North America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 113: North America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 114: North America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 115: North America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 116: North America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 117: North America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 118: North America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
Figure 119: United States Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 120: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)
Figure 121: United States Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 122: United States Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 123: United States Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 124: United States Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 125: United States Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 126: United States Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 127: Canada Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 128: Canada Hospital Establishments, By Region, 2019 (Units)
Figure 129: Canada Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 130: Canada Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 131: Canada Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 132: Canada Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 133: Canada Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 134: Canada Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 135: Mexico Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 136: Mexico Promotional Mortality (Percentage of All Deaths, By Disease, 2019
Figure 137: Mexico Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 138: Mexico Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 139: Mexico Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 140: Mexico Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 141: Mexico Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 142: Mexico Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 143: South America Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
Figure 144: South America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 145: South America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 146: South America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 147: South America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 148: South America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 149: South America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 150: South America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F
Figure 151: Brazil Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 152: Brazil Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 153: Brazil Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 154: Brazil Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 155: Brazil Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 156: Brazil Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 157: Brazil Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 158: Argentina Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 159: Argentina, Per Capita Health Expenditure, By Sector (USD), 2020E
Figure 160: Argentina Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 161: Argentina Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 162: Argentina Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 163: Argentina Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 164: Argentina Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 165: Argentina Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 166: Colombia Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)
Figure 167: Colombia Healthcare Expenditure, By Value, USD Billion, 2015-2020E
Figure 168: Colombia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 169: Colombia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 170: Colombia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 171: Colombia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F
Figure 172: Colombia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F
Figure 173: Colombia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F
Figure 174: Middle East & Africa Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)
Figure 175: Middle East & Africa Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F
Figure 176: Middle East & Africa Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F
Figure 177: Middle East & Africa Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F
Figure 178: Middle East & Afr